Recruitment, Retention, And Relationships In Your Rare Program

When it comes to treating rare diseases, Rho understands that advancements don’t come easy and the rarity of the diseases alone can hinder patient recruitment and retention.

Fortunately, understanding patient and caregiver motivations along with strong site and advocacy group relationships can help simplify recruitment and increase retention—ultimately providing more feasible and flexible rare disease clinical trials.